Literature DB >> 6150830

Cimetidine and dapsone acetylation.

J T Wright, R P Goodman, A M Bethel, C M Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150830

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  8 in total

1.  The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.

Authors:  M D Coleman; A K Scott; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

3.  Acetylator polymorphism in Parkinson's disease.

Authors:  J M Ladero; F J Jimenez; J Benitez; M J Fernandez-Gundin; C Martinez; A Llerena; J Cobaleda; J J Muñoz
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

5.  The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.

Authors:  M D Coleman; L E Rhodes; A K Scott; J L Verbov; P S Friedmann; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

6.  An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.

Authors:  M D Tingle; M D Coleman; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 7.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

8.  Lack of inhibition of tolbutamide hydroxylation by cimetidine in man.

Authors:  C Stockley; J Keal; P Rolan; F Bochner; A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.